AstraZeneca Pauses £200 Million UK Research Site Expansion in Cambridge
TEHRAN (Tasnim) – AstraZeneca has suspended a planned £200 million expansion of its Cambridge research facility in eastern England.

Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
2023-08-18 21:07:31 2023-08-18 21:07:31 501195
Total Vote: 3
Yes